Fiji vs Luxembourg: Previously treated cases tested for RR-/MDR-TB
Fiji
100.0%
in 2024
Luxembourg
100.0%
in 2024
Fiji rank
1st
Luxembourg rank
1st
Previously treated cases tested for RR-/MDR-TB over time
- Fiji
- Luxembourg
How they compare
Fiji currently reports 100.0% against 100.0% in Luxembourg, a difference of 0.0%.
The two have swapped places 2 times across 7 shared years of data; in 2011 it was Luxembourg ahead.
Fiji ranks 1st and Luxembourg ranks 1st of 180 countries.
Luxembourg has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Fiji | Luxembourg | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 3.9% | 100.0% | 96.2% | Luxembourg |
| 2020s | 81.8% | 95.0% | 13.2% | Luxembourg |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher previously treated cases tested for rr-/mdr-tb, Fiji or Luxembourg?
- Fiji, at 100.0% against 100.0% in Luxembourg as of 2024.
- What is the difference in previously treated cases tested for rr-/mdr-tb between Fiji and Luxembourg?
- 0.0%, with Fiji ahead.
- How many years of comparable data are there for Fiji and Luxembourg?
- 7 years are reported by both, from 2011 to 2024.
- How do Fiji and Luxembourg rank globally for previously treated cases tested for rr-/mdr-tb?
- Fiji ranks 1st and Luxembourg ranks 1st of 180 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Previously treated cases tested for RR-/MDR-TB (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.